Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inside the stemness engine: Mechanistic links between deregulated transcription factors and stemness in cancer
Egle-Helene Ervin, Rhiannon French, Chao‐Hui Chang, et al.
Seminars in Cancer Biology (2022) Vol. 87, pp. 48-83
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

CircRNAs: Pivotal modulators of TGF-β signalling in cancer pathogenesis
Asif Ahmad Bhat, Gaurav Gupta, Rajiv Dahiya, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 277-287
Open Access | Times Cited: 15
The Effect of Oxidative Phosphorylation on Cancer Drug Resistance
Ziyi Zhao, Yong Mei, Ziyang Wang, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 62-62
Open Access | Times Cited: 54
Targeting the immune privilege of tumor-initiating cells to enhance cancer immunotherapy
Chen Yang, Haigang Geng, Xupeng Yang, et al.
Cancer Cell (2024) Vol. 42, Iss. 12, pp. 2064-2081.e19
Closed Access | Times Cited: 10
Cancer Stem Cells in Pancreatic Ductal Adenocarcinoma
Roman Bubin, Romans Uljanovs, Ilze Štrumfa
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7030-7030
Open Access | Times Cited: 14
The pRb/RBL2-E2F1/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry/exit by paracrine mechanisms
Chao‐Hui Chang, Feng Liu, Stefania Militi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Neoadjuvant fuzuloparib combined with abiraterone for localized high-risk prostate cancer (FAST-PC): A single-arm phase 2 study
Tingwei Zhang, Beihe Wang, Wei Yu, et al.
Cell Reports Medicine (2025), pp. 102018-102018
Open Access
Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance
Tongxuan Shang, Ziqi Jia, J. Li, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
BRD9-SMAD2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma
Yuliang Feng, Liuyang Cai, Martin Pook, et al.
Gastroenterology (2023) Vol. 166, Iss. 1, pp. 139-154
Open Access | Times Cited: 8
MAP7 drives EMT and cisplatin resistance in ovarian cancer via wnt/β-catenin signaling
Qingqing Chen, Shaojing Li, Furong Fu, et al.
Heliyon (2024) Vol. 10, Iss. 9, pp. e30409-e30409
Open Access | Times Cited: 2
Epithelial–mesenchymal plasticity in cancer: signaling pathways and therapeutic targets
Xiangpeng Wang, Xiaoxia Xue, Mingshi Pang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 2
Hypoxia-induced epigenetic regulation of breast cancer progression and the tumour microenvironment
Alina L. Capatina, Jodie R. Malcolm, Jack Stenning, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
The molecular features of lung cancer stem cells (LCSCs) in dedifferentiation process-driven epigenetic alterations
Valentina Masciale, Federico Banchelli, Giulia Grisendi, et al.
Journal of Biological Chemistry (2024), pp. 107994-107994
Open Access | Times Cited: 2
Structural characterization of stem cell factors Oct4, Sox2, Nanog and Esrrb disordered domains, and a method to detect phospho-dependent binding partners
Chafiaa Bouguechtouli, Rania Ghouil, Ania Alik, et al.
Comptes Rendus Chimie (2024) Vol. 26, Iss. S3, pp. 1-19
Open Access | Times Cited: 1
Cancer Stem Cells: Robust Features and Therapeutic Targets
Marwa M. Abu‐Serie, Eman Sarhan
Interdisciplinary cancer research (2024)
Closed Access | Times Cited: 1
Cell Migration–Proliferation Dichotomy in Cancer: Biological Fact or Experimental Artefact?
Abdulaziz Alfahed
Biology (2024) Vol. 13, Iss. 10, pp. 753-753
Open Access | Times Cited: 1
The metabolic crosstalk of cancer-associated fibroblasts and tumor cells: Recent advances and future perspectives
Bing Xia, Liqing Qiu, Jing Yue, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189190-189190
Closed Access | Times Cited: 1
Structural characterization of stem cell factors Oct4, Sox2, Nanog and Esrrb disordered domains, and a method to identify their phospho-dependent binding partners
Chafiaa Bouguechtouli, Rania Ghouil, Ania Alik, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Mannose-Binding Lectin 2 as a Potential Therapeutic Target for Hepatocellular Carcinoma: Multi-Omics Analysis and Experimental Validation
Hangyu Liao, Jun Yang, Yuyan Xu, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4900-4900
Open Access | Times Cited: 2
Circulating tumor cells in lung cancer: Integrating stemness and heterogeneity to improve clinical utility
Teresa Beninato, Giuseppe Lo Russo, Rita Leporati, et al.
International review of cell and molecular biology (2024)
Closed Access
Development of stemness-related signature to optimize prognosis prediction and identify XMD8-85 as a novel therapeutic compound for glioma
Wanxiang Niu, Huihan Yu, Xiaoqing Fan, et al.
Cellular Signalling (2024) Vol. 120, pp. 111231-111231
Closed Access
Quantitative secretomics identifies ligand-receptor pairs in pancreatic cancer that mediate bidirectional crosstalk between cancer stem cells and nociceptors
Chao‐Hui Chang, Feng Liu, Siwei Deng, et al.
Research Square (Research Square) (2024)
Open Access
CD146, a therapeutic target involved in cell plasticity
Zhenhua Wu, Yuzhe Zang, Chuyi Li, et al.
Science China Life Sciences (2024) Vol. 67, Iss. 8, pp. 1563-1578
Closed Access
Regulation of transcription factor function by purinergic signalling in cardiovascular diseases
Hao Tang, Qihang Kong, Zhewei Zhang, et al.
Purinergic Signalling (2024)
Closed Access
Low-dose SAHA enhances CD8+ T cell-mediated antitumor immunity by boosting MHC I expression in non-small cell lung cancer
Wenqian Dong, Bing He, Yanhong Cao, et al.
Cellular Oncology (2024) Vol. 48, Iss. 1, pp. 249-264
Open Access
PIEZO1 mediates matrix stiffness-induced tumor progression in kidney renal clear cell carcinoma by activating the Ca2+/Calpain/YAP pathway
Biqiang Zhu, Li Fan, Jiajun Yu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1872, Iss. 1, pp. 119871-119871
Closed Access
Page 1 - Next Page

Scroll to top